Knee implant study for people with osteoarthritis on the inner side of the knee
Tests the MISHA Knee System in people with inner-knee osteoarthritis, followed 5 years.
Key facts
- Who runs it
- Moximed
- Where
- Charlottesville, Portland, Raleigh, and Sonoma, United StatesSee the 4 sites
- Trial code
- Registry title
- MISHA Post-Market Clinical Study
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 3 Nov 2023
- Expected to end
- 30 Jul 2030
- Type of study
- Interventional
- Treatments tested
- MISHA Knee System
- Record updated
- 14 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with knee osteoarthritis pain on the inner (medial) side of the knee. They receive the MISHA Knee System implant.
- Age
- 25 to 65 years at the time of the procedure
- Sex
- All sexes
- Disease stage
- Knee pain that gets worse with activity, only in the inner (medial) part of the knee, not the whole knee. WOMAC pain score of 40 or more.
- Earlier treatment
- Osteoarthritis treatment without surgery must have failed.
- Biomarker or test result
- Body Mass Index (BMI) under 35.
Main reasons for not taking part
- Large bone spurs or a pushed-out meniscus on the inner knee that could get in the way of the device
- Weak bones, such as osteopenia, osteoporosis or bone erosion
- Loose or unstable knee ligaments
- Active or recent knee infection, or inflammatory joint disease
- Allergy to cobalt, chromium, nickel or other metals, or a history of thick or tight scarring
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Subjects aged 25 to 65 years at time of index procedure
- Body Mass Index (BMI) of < 35
- Activity exacerbated knee pain isolated to the medial compartment and not global in nature
- WOMAC pain ≥ 40
- Failed non-operative OA treatment
Who cannot take part
- Propensity for restrictive scar formation or adhesions with prior procedures
- Active or recent knee infection
- Inflammatory joint disease, including sequalae of viral infections
- Suspected or documented allergy or hypersensitivity to cobalt, chromium, nickel or other metals
- History of keloid, hypertrophic or contracture scaring
- Large medial osteophyte(s) or considerable extruded meniscus that may interfere with the placement or function of the device
- Poor bone quality (e.g., bony erosion, osteopenia, osteoporosis)
- Ligamentous instability
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 25 and 65 years old?
Where in United States
- University of VirginiaCharlottesville, United StatesContact: David Diduch, MDTaking people
- Oregon Health and Science UniversityPortland, United StatesContact: Dennis Crawford, MDTaking people
- Orthopaedics Specialists of NCRaleigh, United StatesContact: Mark Galland, MDTaking people
- Weiss OrthopedicsSonoma, United StatesContact: Noah WeissTaking people
About the trial
What the trial wants to find out
Prospective evaluation of the safety and effectiveness of the MISHA Knee System.
Read full original descriptionShow less
The study will collect data on the procedural and long-term adverse events, WOMAC pain and function scores, KSS satisfaction, subsequent surgical interventions, BMI levels, range of motion, UCLA activity level of the subjects, and perform radiographic/x-ray evaluations at clinical visits through 5 years post-procedure.
The primary analysis of this study is freedom from device- and procedure-related SSIs at five (5) years post-implantation.
This study will also assess device performance in subjects with intact and retained devices and subjects with devices removed prior to study termination and freedom from conversion to arthroplasty through 5 years.
Study subjects will be followed over a five-year post-implant period.
The group in the trial
- MISHA Knee SystemTreatment being tested
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Post-Market Evaluation of the MISHA® Knee System for Symptom Relief in Subjects With Medial Knee Osteoarthritis
- Plain-language title
- Knee implant study for people with osteoarthritis on the inner side of the kneeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06118892, who can take part
- Record updated
- 14 July 2026